arrow
A

Arzu Yaşar

ankara university school of medicine
H指数:9
被引数:282

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Upfront Versus Deferred CDK4/6 Inhibitor Use in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Real-World Study

激素受体阳性、HER2阴性转移性乳腺癌中即刻与延迟使用CDK4/6抑制剂:一项真实世界研究

2026-08-290
OA
Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study

索拉非尼治疗放射性碘难治性分化型甲状腺癌患者的真实世界结果及预后因素:一项多中心研究

2026-06-240
OAAI
Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study

与健康相关的生活质量和免疫检查点抑制剂治疗长期存活者的心理社会结局:一项全国性多中心研究

2025-12-100
OA
Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study

抗VEGF和抗EGFRs在微卫星不稳定(MSI-H)转移性结直肠癌中的疗效:土耳其肿瘤学组(TOG)队列研究

2025-11-180
OAAI
Metabolic dysfunction-associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad

代谢功能障碍相关脂肪性肝病、胰岛素抵抗和肝细胞癌:一个致命的三联征

2025-10-100
OAAI